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**Abstract**

Substantial evidence shows a role for the dopamine system in schizophrenia. However, studies indicate that it is not the dopamine neurons themselves that are responsible for these pathological states, but instead the disorder appears to arise due to a disruption of dopamine neuron regulation by afferent inputs. Dopamine neurons recorded in vivo are known to exhibit multiple functional activity states, including baseline tonic firing and phasic activation in response to salient stimuli. Phasic burst firing is believed to be the behaviorally relevant "signal" of the dopamine neuron, whereas the level of tonic discharge represents the "gain" or the level of amplification of this signal. This tonic gain is differentially regulated by multiple brain regions, with the ventral hippocampus playing a major role. Using the MAM developmental disruption model of schizophrenia in rats, we found that parvalbumin interneuron loss in the hippocampus leads to abnormally high tonic dopamine neuron firing, causing the system to be hyper-responsive to phasic stimuli. This would lead to over- or misinterpretation of external events. Restoring GABAergic balance in the hippocampus by a selective GABA A alpha 5 positive allosteric modulator restores baseline dopamine neuron firing and behavioral responses to amphetamine. In contrast, this drug is not effective if the rats are pre-treated with a D2 blocking antipsychotic drug, which has implications for the failure of novel target compounds in clinical trials.

This disruption in hippocampal interneurons appears to be driven by abnormal responses to stress occurring in the peripubertal time period. Thus, in MAM rats there is hyperactivity peripubertally both in the amygdala and in its target area, the ventral hippocampus. Such hyperactivity is proposed to lead to the interneuron loss, thereby producing abnormal hippocampal function in the adult. We found that administration of an anti-anxiety drug during the peripubertal period at doses that relieve the hyperanxious state prevents the development of dopamine system hyper-responsivity in the adult rat. Therefore, examining the circuitry underlying dopamine system disruption in this developmental model of psychosis can contribute both to a better understanding of the pathophysiology of major psychiatric disorders, as well as glean insights into novel avenues of treatment and potentially in preventing the emergence of schizophrenia in susceptible individuals.
